Preliminary Findings: RSV Vaccines Potentially Linked to Rare Nerve Disorder Risk

Early Data Points to Possible Guillain-Barré Syndrome Risk with RSV Vaccine

Recent data suggest new RSV vaccines might slightly increase the risk of Guillain-Barré syndrome (GBS). This information comes from the CDC and FDA.

Experts shared these findings at an Advisory Committee on Immunization Practices meeting. They noted a higher GBS rate in those vaccinated with Pfizer's RSV vaccine. GSK vaccine recipients also reported cas…